SCHEMBL4352960

SCHEMBL4352960

Nc1ncnc2[nH]cc(-c3ccc(F)cc3)c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 6/20 0.58
STK3 Q13188 3/20 0.58
STK4 Q13043 2/20 0.58
HPGD P15428 2/20 0.48
PTK2B Q14289 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
PDPK1 O15530 2/20 0.47
MET P08581 2/20 0.47
KDM4E B2RXH2 1/20 0.47
PPARG P37231 1/20 0.47
MCL1 Q07820 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
NR2E3 Q9Y5X4 1/20 0.47
NCOR2 Q9Y618 1/20 0.47
AXL P30530 1/20 0.46
DYRK1A Q13627 2/20 0.46
FLT3 P36888 3/20 0.46
JAK3 P52333 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24710755 0.87 LRRK2 (0.51) LRRK2STK3STK4PTK2BPDPK1
SCHEMBL8107167 0.84 FLT3 (0.46) LRRK2STK3STK4PTK2BPDPK1
SCHEMBL1896766 0.84 STK3 (0.58) LRRK2STK3STK4HPGDPTK2B
SCHEMBL23917432 0.84 LRRK2 (0.50) LRRK2STK3PTK2BPDPK1AXL
SCHEMBL3787081 0.84 SRC (0.50) LRRK2STK3STK4PDPK1AXL
SCHEMBL7021288 0.83 LRRK2 (0.63) LRRK2STK3STK4PTK2BPDPK1
SCHEMBL8107173 0.83 FLT3 (0.46) LRRK2STK3STK4PTK2BPDPK1
SCHEMBL28057752 0.82 RET (0.48) LRRK2STK3STK4PTK2BPDPK1
SCHEMBL31531349 0.82 FLT3 (0.51) LRRK2STK3STK4PDPK1MET
SCHEMBL4353306 0.82 LRRK2 (0.62) LRRK2STK3STK4JAK3MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009070328-A1 MODULATORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY FOR USE IN THE TREATMENT OR PREVENTION OF SUBSTANCE ABUSE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-06-04 WO disclosed
US-6051577-A TYROSINE INHIBITORS; BONE DISORDERS NOVARTIS AG (CH) 2000-04-18 US disclosed
EP-0888353-A1 NOVEL N-7-HETEROCYCLYL PYRROLO 2,3-D]PYRIDINES AND THEIR USE Novartis AG (CH) 1999-01-07 EP disclosed
WO-1997034895-A1 NOVEL N-7-HETEROCYCLYL PYRROLO[2,3-D]PYRIDINES AND THEIR USE NOVARTIS AG (CH) 1997-09-25 WO disclosed
WO-1997032879-A1 7-ALKYL-PYRROLO[2,3-d]PYRIMIDINES NOVARTIS AG (CH) 1997-09-12 WO disclosed